Scientists Discover Amazing New Benefit of Ozempic
Weight Loss Drugs Like Ozempic, Wegovy May Help Fight Alcoholism and Opioid Addiction
A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds Ozempic, Wegovy, Mounjaro or Zepbound, may help users overcome alcoholism and opioid addiction.
Scientists Discover Amazing New Benefit of Ozempic: Reducing Alcohol and Opioid Addiction
New research shows that Ozempic and similar drugs reduce opioid overdoses by 40% and alcohol intoxication by 50% in people with substance use disorders. These medications, often prescribed for diabetes and weight issues,
Ozempic (and similar medications) may be the new treatment for opioid and alcohol use disorder
A new study published in the scientific journal Addiction has found that people with opioid or alcohol use disorder (OUD, AUD) who take Ozempic or similar medications to treat diabetic/weight-related conditions appear to have a 40% lower rate of opioid overdose and a 50% lower rate of alcohol intoxication than people with OUD and AUD who do not take Ozempic or similar medications.
Ozempic: Weight Loss Drug May Help With Addiction Too
These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.
Ozempic shows promise for treating alcohol and drug abuse, study finds
The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down substance use cravings too.
Ozempic may help battle drug and alcohol addiction
Weight-loss drugs like Ozempic and Mounjaro, which also treat diabetes, may help users battling drug and alcohol abuse as well. A study published in the Addiction medical journal Wednesday showed roughy 1.
Weight-loss drugs could reduce risk of overdoses, new study says
A new study suggests that medications like Ozempic could help reduce the risk of overdose and alcohol intoxication in people ...
Managed Healthcare Executive1d
In the Real World, People Do Not Stick With GLP-1s for Weight Loss | AMCP Nexus 2024
Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...
Daily18h
Glucagon-like peptide-1 receptor agonists may be new treatment for opioid and alcohol use disorder, finds study
Ozempic is one of several medications, called glucagon-like peptide-1 receptor agonists or GLP-1 RAs, that are prescribed to ...
ConsumerAffairs1d
Ozempic vs. Wegovy: Which is best for weight loss?
FDA approval: Ozempic is FDA-approved for Type 2 diabetes, while Wegovy is FDA-approved for weight loss. Cost: Ozempic is ...
ahajournals.org8d
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and ...
Health on MSN2d
How Much Weight Can You Lose on a GLP-1 Drug? It Depends on These Factors
Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and ...
Ozempic could cut binge drinking and opioid abuse
Ozempic could cut binge drinking and opioid abuse, major research suggests. A US study of more than 800,000 people with a ...
healthday on MSN3d
Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity
For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduc ...
rheumatologyadvisor1d
Diabetes, High BMI, Previous Metformin Common in Teens With Rx for GLP-1 RAs
Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have comorbid type 2 diabetes, high body mass index, and a previous metformin ...